Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
-$56,000 |
 |
Tempus AITEM |
$83,000 |
 |
TeleflexTFX |
-$33,000 |
 |
HCA HealthcareHCA |
-$57,000 |
 |
ProgynyPGNY |
-$8,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson | Jan 15, 2025 | Sell | $1K - $15K |
| Gary Peters Democrat | May 14, 2024 | Buy | $1K - $15K |
Who is the latest politician to buy or sell Solventum shares?
Julie Johnson sold Solventum shares most recently on January 15, 2025.
Which politician has sold the most SOLV stock over the last two years?
Julie Johnson has sold the most SOLV stock in the last 2 years, with an estimated value of $8,000.
What is the total value of politicians trading SOLV stock in the last 2 years?
The net value of trades by US politicians for Solventum in the last 2 years is negative, amounting to -$8,000. This suggests that US politicians do not believe in the success of the company for various reasons.
How do insider transactions over the last 2 years reflect on Solventum's market confidence?
Over the last 2 years, insider transactions for Solventum have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
